Skip to main content
Erschienen in: Archives of Dermatological Research 7/2023

23.03.2023 | Consensus Article

Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study

verfasst von: Mika Yamanaka-Takaichi, Rishab Revankar, Terri Shih, Margaret Gall, Jennifer L. Hsiao, Vivian Y. Shi, Afsaneh Alavi

Erschienen in: Archives of Dermatological Research | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Hidradenitis suppurativa (HS) is a debilitating systemic inflammatory disease with limited treatment options. Although management through dietary and lifestyle changes is a primary interest of the HS patient community, there is lack of consensus regarding recommendations due to the paucity of evidence. To establish the priority research gaps on this topic, we performed and moderated a Delphi consensus study by integrating expert opinions and the relevant literature. Based on a literature review, research questions on dietary and lifestyle interventions in HS were constructed. HS dietary and lifestyle research questions were sent to an expert panel, consisting of 22 international members, including dermatologists, dietitians, pharmacists, and endocrinologists. Voting on the research questions was conducted using a modified Delphi technique. The primary outcome measure was whether participants could reach consensus on the priority of each research question in the HS dietary and lifestyle factors. After three rounds of surveys investigating the relationships between HS and various diet and lifestyle factors, “BMI”, “Obesity”, and “Smoking”, reached consensus as high priority research questions. Low research priorities per consensus included “effects of iron supplements”, “effects of magnesium supplements”, “alcohol consumption” and “limiting Brewer's yeast intake. Smoking and obesity were identified as important research questions, concurrent to the literature indicating their association with more significant impact on disease activity. By shedding light on high priority research questions, our study provides a roadmap for further research on dietary and lifestyle modifications in HS and will help determine evidence-based lifestyle and dietary recommendations for patients with HS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C et al (2019) North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol 81:76–90PubMedPubMedCentral Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C et al (2019) North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol 81:76–90PubMedPubMedCentral
2.
Zurück zum Zitat Nesbitt E, Clements S, Driscoll M (2020) A concise clinician’s guide to therapy for hidradenitis suppurativa. Int J Women’s Dermatol 6:80–84 Nesbitt E, Clements S, Driscoll M (2020) A concise clinician’s guide to therapy for hidradenitis suppurativa. Int J Women’s Dermatol 6:80–84
3.
Zurück zum Zitat Revankar R, Murrell DF, Murase JE (2021) Shedding light on the impact of hidradenitis suppurativa on women and their families: a focus of the International Journal of Women’s Dermatology. Int J Women’s Dermatol 7:661–663 Revankar R, Murrell DF, Murase JE (2021) Shedding light on the impact of hidradenitis suppurativa on women and their families: a focus of the International Journal of Women’s Dermatology. Int J Women’s Dermatol 7:661–663
4.
Zurück zum Zitat Alavi A, Farzanfar D, Rogalska T, Lowes MA, Chavoshi S (2018) Quality of life and sexual health in patients with hidradenitis suppurativa. Int J Women’s Dermatol 4:74–79 Alavi A, Farzanfar D, Rogalska T, Lowes MA, Chavoshi S (2018) Quality of life and sexual health in patients with hidradenitis suppurativa. Int J Women’s Dermatol 4:74–79
5.
Zurück zum Zitat Machado MO, Stergiopoulos V, Maes M, Kurdyak PA, Lin PY, Wang LJ et al (2019) Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis. JAMA Dermatol 155:939–945PubMedPubMedCentral Machado MO, Stergiopoulos V, Maes M, Kurdyak PA, Lin PY, Wang LJ et al (2019) Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis. JAMA Dermatol 155:939–945PubMedPubMedCentral
6.
Zurück zum Zitat Wright S, Strunk A, Garg A (2022) Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa. J Am Acad Dermatol 86:55–60PubMed Wright S, Strunk A, Garg A (2022) Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa. J Am Acad Dermatol 86:55–60PubMed
7.
Zurück zum Zitat Attanoos RL, Appleton MA, Douglas-Jones AG (1995) The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 133:254–258PubMed Attanoos RL, Appleton MA, Douglas-Jones AG (1995) The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 133:254–258PubMed
8.
Zurück zum Zitat Cartron A, Driscoll MS (2019) Comorbidities of hidradenitis suppurativa: a review of the literature. Int J Women’s Dermatol 5:330–334 Cartron A, Driscoll MS (2019) Comorbidities of hidradenitis suppurativa: a review of the literature. Int J Women’s Dermatol 5:330–334
9.
Zurück zum Zitat Fimmel S, Zouboulis CC (2010) Comorbidities of hidradenitis suppurativa (acne inversa). Dermato-endocrinology 2:9–16PubMedPubMedCentral Fimmel S, Zouboulis CC (2010) Comorbidities of hidradenitis suppurativa (acne inversa). Dermato-endocrinology 2:9–16PubMedPubMedCentral
10.
Zurück zum Zitat Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R et al (2022) Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol 86:1092–1101PubMed Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R et al (2022) Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol 86:1092–1101PubMed
11.
Zurück zum Zitat Tzellos T, Zouboulis CC (2020) Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice. Dermatol Ther 10:63–71 Tzellos T, Zouboulis CC (2020) Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice. Dermatol Ther 10:63–71
12.
Zurück zum Zitat Cannistra C, Finocchi V, Trivisonno A, Tambasco D (2014) New perspectives in the treatment of hidradenitis suppurativa (surgery and brewer’s yeast-exclusion diet): some clarifications. Surgery 156:736PubMed Cannistra C, Finocchi V, Trivisonno A, Tambasco D (2014) New perspectives in the treatment of hidradenitis suppurativa (surgery and brewer’s yeast-exclusion diet): some clarifications. Surgery 156:736PubMed
13.
Zurück zum Zitat Fernandez JM, Marr KD, Hendricks AJ, Price KN, Ludwig CM, Maarouf M et al (2020) Alleviating and exacerbating foods in hidradenitis suppurativa. Dermatol Ther 33:e14246PubMed Fernandez JM, Marr KD, Hendricks AJ, Price KN, Ludwig CM, Maarouf M et al (2020) Alleviating and exacerbating foods in hidradenitis suppurativa. Dermatol Ther 33:e14246PubMed
14.
Zurück zum Zitat Dempsey A, Butt M, Kirby JS (2020) Prevalence and impact of dietary avoidance among individuals with hidradenitis suppurativa. Dermatology (Basel, Switzerland) 236:289–295PubMed Dempsey A, Butt M, Kirby JS (2020) Prevalence and impact of dietary avoidance among individuals with hidradenitis suppurativa. Dermatology (Basel, Switzerland) 236:289–295PubMed
15.
Zurück zum Zitat Li W, Ma JE, Chan AA, Lee DJ, Smogorzewski J (2021) Hidradenitis suppurativa through the lens of YouTube: a cross-sectional analysis. J Am Acad Dermatol 84:1398–1399PubMed Li W, Ma JE, Chan AA, Lee DJ, Smogorzewski J (2021) Hidradenitis suppurativa through the lens of YouTube: a cross-sectional analysis. J Am Acad Dermatol 84:1398–1399PubMed
16.
Zurück zum Zitat Yesantharao LV, Suresh R, Lerman SF, Cox C, Caffrey J (2022) Hidradenitis suppurativa reddit support group: finding new meaning in social media during the COVID-19 pandemic. J Burn Care Res 44:373–380 Yesantharao LV, Suresh R, Lerman SF, Cox C, Caffrey J (2022) Hidradenitis suppurativa reddit support group: finding new meaning in social media during the COVID-19 pandemic. J Burn Care Res 44:373–380
17.
Zurück zum Zitat Lukac D, Pagani K, Yi JZ, McGee JS (2022) Consulting “Dr YouTube”: a content analysis of YouTube(®) videos related to hidradenitis suppurativa treatments. Clin Exp Dermatol 47:606–608PubMed Lukac D, Pagani K, Yi JZ, McGee JS (2022) Consulting “Dr YouTube”: a content analysis of YouTube(®) videos related to hidradenitis suppurativa treatments. Clin Exp Dermatol 47:606–608PubMed
18.
Zurück zum Zitat Eubank BH, Mohtadi NG, Lafave MR, Wiley JP, Bois AJ, Boorman RS et al (2016) Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology. BMC Med Res Methodol 16:56PubMedPubMedCentral Eubank BH, Mohtadi NG, Lafave MR, Wiley JP, Bois AJ, Boorman RS et al (2016) Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology. BMC Med Res Methodol 16:56PubMedPubMedCentral
19.
Zurück zum Zitat Alavi A, Lynde C, Alhusayen R, Bourcier M, Delorme I, George R et al (2017) Approach to the management of patients with hidradenitis suppurativa: a consensus document. J Cutan Med Surg 21:513–524PubMed Alavi A, Lynde C, Alhusayen R, Bourcier M, Delorme I, George R et al (2017) Approach to the management of patients with hidradenitis suppurativa: a consensus document. J Cutan Med Surg 21:513–524PubMed
20.
Zurück zum Zitat Walker A, Selfe J (1996) The Delphi method: a useful tool for the allied health researcher. Br J Ther Rehabil 3:677–681 Walker A, Selfe J (1996) The Delphi method: a useful tool for the allied health researcher. Br J Ther Rehabil 3:677–681
21.
Zurück zum Zitat Lilja KK, Laakso K , Palomäki J (2011) Using the Delphi method. In: 2011 Proceedings of PICMET'11: Technology Management in the Energy Smart World (PICMET): IEEE, pp 1–10 Lilja KK, Laakso K , Palomäki J (2011) Using the Delphi method. In: 2011 Proceedings of PICMET'11: Technology Management in the Energy Smart World (PICMET): IEEE, pp 1–10
22.
Zurück zum Zitat Clair JS (2005) Advances in patient safety: a new model of tracheostomy care: closing the research–practice gap. In: Henriksen K, Battles JB, Marks ES, Lewin DI (eds) Advances in patient safety: from research to implementation (volume 3: implementation issues). Agency for Healthcare Research and Quality (US), Rockville Clair JS (2005) Advances in patient safety: a new model of tracheostomy care: closing the research–practice gap. In: Henriksen K, Battles JB, Marks ES, Lewin DI (eds) Advances in patient safety: from research to implementation (volume 3: implementation issues). Agency for Healthcare Research and Quality (US), Rockville
23.
Zurück zum Zitat Molinelli E, Brisigotti V, Campanati A, Sapigni C, Giacchetti A, Cota C et al (2020) Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: a controlled retrospective clinical study. J Am Acad Dermatol 83:665–667PubMed Molinelli E, Brisigotti V, Campanati A, Sapigni C, Giacchetti A, Cota C et al (2020) Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: a controlled retrospective clinical study. J Am Acad Dermatol 83:665–667PubMed
24.
Zurück zum Zitat Guillet A, Brocard A, Bach Ngohou K, Graveline N, Leloup AG, Ali D et al (2015) Verneuil’s disease, innate immunity and vitamin D: a pilot study. JEADV 29:1347–1353PubMed Guillet A, Brocard A, Bach Ngohou K, Graveline N, Leloup AG, Ali D et al (2015) Verneuil’s disease, innate immunity and vitamin D: a pilot study. JEADV 29:1347–1353PubMed
25.
Zurück zum Zitat Frew JW, Singh N, Jiang CS, Vaughan R, Krueger JG (2021) The impact of body mass index upon the efficacy of adalimumab in hidradenitis suppurativa. Front Med 8:603281 Frew JW, Singh N, Jiang CS, Vaughan R, Krueger JG (2021) The impact of body mass index upon the efficacy of adalimumab in hidradenitis suppurativa. Front Med 8:603281
26.
Zurück zum Zitat Jørgensen AR, Yao Y, Thomsen SF, Ring HC (2021) Treatment of hidradenitis suppurativa with tetracycline, doxycycline, or lymecycline: a prospective study. Int J Dermatol 60:785–791PubMed Jørgensen AR, Yao Y, Thomsen SF, Ring HC (2021) Treatment of hidradenitis suppurativa with tetracycline, doxycycline, or lymecycline: a prospective study. Int J Dermatol 60:785–791PubMed
27.
Zurück zum Zitat Iannone M, Janowska A, Bartolomei G, Puntoni M, Oranges T, Romanelli M et al (2021) Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack-year on the response to therapy. Dermatol Ther 34:e14919PubMed Iannone M, Janowska A, Bartolomei G, Puntoni M, Oranges T, Romanelli M et al (2021) Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack-year on the response to therapy. Dermatol Ther 34:e14919PubMed
28.
Zurück zum Zitat Garcovich S, Fania L, Caposiena D, Giovanardi G, Chiricozzi A, De Simone C et al (2022) Pediatric hidradenitis suppurativa: a cross-sectional study on clinical features and treatment approaches. J Cutan Med Surg 26:127–134PubMed Garcovich S, Fania L, Caposiena D, Giovanardi G, Chiricozzi A, De Simone C et al (2022) Pediatric hidradenitis suppurativa: a cross-sectional study on clinical features and treatment approaches. J Cutan Med Surg 26:127–134PubMed
29.
Zurück zum Zitat Fabbrocini G, De Vita V, Donnarumma M, Russo G, Monfrecola G (2016) South Italy: a privileged perspective to understand the relationship between hidradenitis suppurativa and overweight/obesity. Skin Append Disord 2:52–56 Fabbrocini G, De Vita V, Donnarumma M, Russo G, Monfrecola G (2016) South Italy: a privileged perspective to understand the relationship between hidradenitis suppurativa and overweight/obesity. Skin Append Disord 2:52–56
30.
Zurück zum Zitat Bianchi L, Caposiena Caro RD, Ganzetti G, Molinelli E, Dini V, Oranges T et al (2019) Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort. Clin Exp Dermatol 44:e177–e180PubMed Bianchi L, Caposiena Caro RD, Ganzetti G, Molinelli E, Dini V, Oranges T et al (2019) Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort. Clin Exp Dermatol 44:e177–e180PubMed
31.
Zurück zum Zitat Schrader AM, Deckers IE, van der Zee HH, Boer J, Prens EP (2014) Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol 71:460–467PubMed Schrader AM, Deckers IE, van der Zee HH, Boer J, Prens EP (2014) Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol 71:460–467PubMed
32.
Zurück zum Zitat Riis PT, Saunte DM, Sigsgaard V, Villani AP, Guillem P, Pascual JC et al (2020) Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients. Arch Dermatol Res 312:715–724PubMed Riis PT, Saunte DM, Sigsgaard V, Villani AP, Guillem P, Pascual JC et al (2020) Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients. Arch Dermatol Res 312:715–724PubMed
33.
Zurück zum Zitat Theut Riis P, Saunte DM, Benhadou F, Del Marmol V, Guillem P, El-Domyati M et al (2018) Low and high body mass index in hidradenitis suppurativa patients-different subtypes? JEADV 32:307–312PubMed Theut Riis P, Saunte DM, Benhadou F, Del Marmol V, Guillem P, El-Domyati M et al (2018) Low and high body mass index in hidradenitis suppurativa patients-different subtypes? JEADV 32:307–312PubMed
34.
Zurück zum Zitat Calao M, Wilson JL, Spelman L, Billot L, Rubel D, Watts AD et al (2018) Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: a population-based cross-sectional study. PLoS ONE 13:e0200683PubMedPubMedCentral Calao M, Wilson JL, Spelman L, Billot L, Rubel D, Watts AD et al (2018) Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: a population-based cross-sectional study. PLoS ONE 13:e0200683PubMedPubMedCentral
35.
Zurück zum Zitat Wright S, Strunk A, Garg A (2021) Trends in body mass index before and after diagnosis of hidradenitis suppurativa. Br J Dermatol 185:74–79PubMed Wright S, Strunk A, Garg A (2021) Trends in body mass index before and after diagnosis of hidradenitis suppurativa. Br J Dermatol 185:74–79PubMed
36.
Zurück zum Zitat Jørgensen AR, Aarestrup J, Baker JL, Thomsen SF (2020) Association of birth weight, childhood body mass index, and height with risk of hidradenitis suppurativa. JAMA Dermatol 156:746–753PubMed Jørgensen AR, Aarestrup J, Baker JL, Thomsen SF (2020) Association of birth weight, childhood body mass index, and height with risk of hidradenitis suppurativa. JAMA Dermatol 156:746–753PubMed
37.
Zurück zum Zitat Kjaersgaard Andersen R, Loft IC, Hansen T, Hjalgrim H, Rostgaard K, Banasik K et al (2022) Incidence and remission rates of self-reported hidradenitis suppurative—a prospective cohort study conducted in Danish blood donors. JEADV 36:717–725PubMed Kjaersgaard Andersen R, Loft IC, Hansen T, Hjalgrim H, Rostgaard K, Banasik K et al (2022) Incidence and remission rates of self-reported hidradenitis suppurative—a prospective cohort study conducted in Danish blood donors. JEADV 36:717–725PubMed
38.
Zurück zum Zitat Dessinioti C, Tzanetakou V, Zisimou C, Kontochristopoulos G, Antoniou C (2018) A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa. Int J Dermatol 57:687–691PubMed Dessinioti C, Tzanetakou V, Zisimou C, Kontochristopoulos G, Antoniou C (2018) A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa. Int J Dermatol 57:687–691PubMed
39.
Zurück zum Zitat Kromann CB, Ibler KS, Kristiansen VB, Jemec GB (2014) The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol 94:553–557PubMed Kromann CB, Ibler KS, Kristiansen VB, Jemec GB (2014) The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol 94:553–557PubMed
40.
Zurück zum Zitat Thomas CL, Gordon KD, Mortimer PS (2014) Rapid resolution of hidradenitis suppurativa after bariatric surgical intervention. Clin Exp Dermatol 39:315–317 (quiz 7–8)PubMed Thomas CL, Gordon KD, Mortimer PS (2014) Rapid resolution of hidradenitis suppurativa after bariatric surgical intervention. Clin Exp Dermatol 39:315–317 (quiz 7–8)PubMed
41.
Zurück zum Zitat Gallagher C, Kirthi S, Burke T, O’Shea D, Tobin AM (2017) Remission of hidradenitis suppurativa after bariatric surgery. JAAD Case Rep 3:436–437PubMedPubMedCentral Gallagher C, Kirthi S, Burke T, O’Shea D, Tobin AM (2017) Remission of hidradenitis suppurativa after bariatric surgery. JAAD Case Rep 3:436–437PubMedPubMedCentral
42.
Zurück zum Zitat Jennings L, Nestor L, Molloy O, Hughes R, Moriarty B, Kirby B (2017) The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide. Br J Dermatol 177:858–859PubMed Jennings L, Nestor L, Molloy O, Hughes R, Moriarty B, Kirby B (2017) The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide. Br J Dermatol 177:858–859PubMed
43.
Zurück zum Zitat Macklis PC, Tyler K, Kaffenberger J, Kwatra S, Kaffenberger BH (2022) Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients. Arch Dermatol Res 314:293–300PubMed Macklis PC, Tyler K, Kaffenberger J, Kwatra S, Kaffenberger BH (2022) Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients. Arch Dermatol Res 314:293–300PubMed
44.
Zurück zum Zitat Boer J (2016) Resolution of hidradenitis suppurativa after weight loss by dietary measures, especially on frictional locations. JEADV 30:895–896PubMed Boer J (2016) Resolution of hidradenitis suppurativa after weight loss by dietary measures, especially on frictional locations. JEADV 30:895–896PubMed
45.
Zurück zum Zitat Sokumbi O, Hodge DO, Ederaine SA, Alavi A, Alikhan A (2022) Comorbid diseases of hidradenitis suppurativa: a 15-year population-based study in Olmsted County, Minnesota, USA. Int J Dermatol 61:1372–1379PubMed Sokumbi O, Hodge DO, Ederaine SA, Alavi A, Alikhan A (2022) Comorbid diseases of hidradenitis suppurativa: a 15-year population-based study in Olmsted County, Minnesota, USA. Int J Dermatol 61:1372–1379PubMed
46.
Zurück zum Zitat Ikeda K, Morizane S, Akagi T, Hiramatsu-Asano S, Tachibana K, Yahagi A et al (2022) Obesity and dyslipidemia synergistically exacerbate psoriatic skin inflammation. Int J Mol Sci 23:4312PubMedPubMedCentral Ikeda K, Morizane S, Akagi T, Hiramatsu-Asano S, Tachibana K, Yahagi A et al (2022) Obesity and dyslipidemia synergistically exacerbate psoriatic skin inflammation. Int J Mol Sci 23:4312PubMedPubMedCentral
47.
Zurück zum Zitat Dajnoki Z, Somogyi O, Medgyesi B, Jenei A, Szabó L, Gáspár K et al (2022) Primary alterations during the development of hidradenitis suppurativa. JEADV 36:462–471PubMed Dajnoki Z, Somogyi O, Medgyesi B, Jenei A, Szabó L, Gáspár K et al (2022) Primary alterations during the development of hidradenitis suppurativa. JEADV 36:462–471PubMed
48.
Zurück zum Zitat Acharya P, Mathur M (2020) Hidradenitis suppurativa and smoking: a systematic review and meta-analysis. J Am Acad Dermatol 82:1006–1011PubMed Acharya P, Mathur M (2020) Hidradenitis suppurativa and smoking: a systematic review and meta-analysis. J Am Acad Dermatol 82:1006–1011PubMed
49.
Zurück zum Zitat Denny G, Anadkat MJ (2017) The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: an institutional retrospective cohort study. J Am Acad Dermatol 76:54–59PubMed Denny G, Anadkat MJ (2017) The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: an institutional retrospective cohort study. J Am Acad Dermatol 76:54–59PubMed
50.
Zurück zum Zitat Sawada Y, Saito-Sasaki N, Mashima E, Nakamura M (2021) Daily lifestyle and inflammatory skin diseases. Int J Mol Sci 22:5204PubMedPubMedCentral Sawada Y, Saito-Sasaki N, Mashima E, Nakamura M (2021) Daily lifestyle and inflammatory skin diseases. Int J Mol Sci 22:5204PubMedPubMedCentral
51.
Zurück zum Zitat Larsson SC, Burgess S (2022) Appraising the causal role of smoking in multiple diseases: a systematic review and meta-analysis of Mendelian randomization studies. EBioMedicine 82:104154PubMedPubMedCentral Larsson SC, Burgess S (2022) Appraising the causal role of smoking in multiple diseases: a systematic review and meta-analysis of Mendelian randomization studies. EBioMedicine 82:104154PubMedPubMedCentral
52.
Zurück zum Zitat Bukvić Mokos Z, Miše J, Balić A, Marinović B (2020) Understanding the relationship between smoking and hidradenitis suppurativa. ADC 28:9–13PubMed Bukvić Mokos Z, Miše J, Balić A, Marinović B (2020) Understanding the relationship between smoking and hidradenitis suppurativa. ADC 28:9–13PubMed
53.
Zurück zum Zitat Barrea L, Fabbrocini G, Annunziata G, Muscogiuri G, Donnarumma M, Marasca C et al (2018) Role of nutrition and adherence to the mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: evaluation of nutritional status and its association with severity of disease. Nutrients 11:57PubMedPubMedCentral Barrea L, Fabbrocini G, Annunziata G, Muscogiuri G, Donnarumma M, Marasca C et al (2018) Role of nutrition and adherence to the mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: evaluation of nutritional status and its association with severity of disease. Nutrients 11:57PubMedPubMedCentral
54.
Zurück zum Zitat Velluzzi F, Anedda J, Pisanu S, Dell’Antonia M, Deledda A, Boi A et al (2021) Mediterranean diet, lifestyle and quality of life in Sardinian patients affected with Hidradenitis suppurativa. J Public Health Res 11:jphr-2021 Velluzzi F, Anedda J, Pisanu S, Dell’Antonia M, Deledda A, Boi A et al (2021) Mediterranean diet, lifestyle and quality of life in Sardinian patients affected with Hidradenitis suppurativa. J Public Health Res 11:jphr-2021
55.
Zurück zum Zitat Lorite-Fuentes I, Montero-Vilchez T, Arias-Santiago S, Molina-Leyva A (2022) Potential benefits of the mediterranean diet and physical activity in patients with hidradenitis suppurativa: a cross-sectional study in a Spanish population. Nutrients 14:551PubMedPubMedCentral Lorite-Fuentes I, Montero-Vilchez T, Arias-Santiago S, Molina-Leyva A (2022) Potential benefits of the mediterranean diet and physical activity in patients with hidradenitis suppurativa: a cross-sectional study in a Spanish population. Nutrients 14:551PubMedPubMedCentral
Metadaten
Titel
Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study
verfasst von
Mika Yamanaka-Takaichi
Rishab Revankar
Terri Shih
Margaret Gall
Jennifer L. Hsiao
Vivian Y. Shi
Afsaneh Alavi
Publikationsdatum
23.03.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 7/2023
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-023-02610-9

Weitere Artikel der Ausgabe 7/2023

Archives of Dermatological Research 7/2023 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.